CRISPR THERAPEUTICS

CRSP
Delayed Quote. Delayed  - 12/07 04:00:00 pm
78.39USD +10.22%

Turn to zoom
Prev.78.3900
Open72.2613
High79.8900
Low72.0300
Volume2 466 444
Latest news
16h ago
11/23
11/23
11/22
Chart CRISPR THERAPEUTICS AG
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance79,9100117
Spread/Res.-1,9%-22%-33%
Spread/Supp.12%12%12%
Support70,170,170,1
Financials
Sales 2021 904 M - -
Net income 2021 386 M - -
Net cash 2021 2 051 M - -
P/E ratio 2021 15,9x
Yield 2021 -
Capitalization 5 999 M 5 999 M -
EV / Sales 2021 4,37x
EV / Sales 2022 115x
Nbr of Employees 410
Free-Float 87,0%
Company
CRISPR Therapeutics AG is a Switzerland-based gene-editing company. It focuses on the development of transformative gene-based medicines for serious diseases. The Company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform, which...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2022-03-11 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 78,39 $
Average target price 154,89 $
Spread / Average Target 97,6%